International Clinical Trial: A Prospective Observational Cohort Study Evaluating Long-term Lipid Goal Achievement and Clinical Outcomes in Patients with Cardiometabolic Diseases Receiving PCSK9 Inhibitors Plus Standard Therapy

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600116995) titled 'A Prospective Observational Cohort Study Evaluating Long-term Lipid Goal Achievement and Clinical Outcomes in Patients with Cardiometabolic Diseases Receiving PCSK9 Inhibitors Plus Standard Therapy' on Jan. 19.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: The First Hospital of Qinhuangdao

Condition: Cardiometabolic Disease

Intervention: PCSK9 group: Addition of PCSK9 inhibitor to standard therapy:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-02-01

Target Sample Size: PCSK9 group: Addition of PCSK9 inhibitor to standard therapy:150;Con...